October 2025 saw a wave of M&As and biotech deals in various therapeutic fields, particularly for therapies addressing ...

Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...

The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in ...

Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.

Discover eight key AI biotech deals that have been made so far in 2025, spotlighting where industry leaders are betting big.

Today, AAVantgarde Bio raises $141 million (€122 million) in a series B round to advance its gene therapy programs for inherited eye diseases, marking one of Europe’s largest private financings in ...

The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...

The now-annual BIOSPAIN partnering conference took place in Barcelona this week. The event attracted the biggest players in the Iberian peninsula’s biotechnology industry and an increasing number of ...

As artificial intelligence (AI) becomes ever more integrated into the world of biotechnology, one of its latest applications is the discovery and design of peptides. This is a rapidly emerging field ...

As well as being known for its historical beauty and academic excellence, Cambridge has a reputation as a leading biotech hub, forming part of the U.K.’s “Golden Triangle” with Oxford and London. This ...

The global biotech industry is booming, and by 2025 it will reach an estimated market worth of $729B. But while great innovation is driven by emerging biotechs, these companies often lack resources, ...